The oversubscribed round was led by Cambridge Enterprise and will fund the company's transition into drug development.
"We are pleased to welcome on board our new investors and appreciate their confidence in our business. Our aim is to replicate the specificity of biologics in the powerful and scalable form of a small molecule, to treat devastating diseases where there are currently no treatment options. We have proven the strength of our platform in tapping unexplored parts of the chemical universe to find novel and specific hits for currently undruggable targets, and are excited to now be able to invest in our own pipeline of drug discovery programmes, as well as to develop further strategic partnerships."
The seed round was led by Global Founders Capital and Partech with backing from existing investors.
"We are excited to find partners who will accompany us on this journey to build new, employer-based trust layers for financial markets and have raised €5.6m from them"
The investment, advised by Izy Capital, will support the ServiceNow partner in scaling toward its long-term revenue targets.
"We are beyond grateful to Lloyds Bank and the Izy Capital team for their help in achieving this massive opportunity. I look forward to working with my co-founder Arron and our growing team toward our vision of building Wales’ first global technology consultancy with £1bn in annual revenue. This injection of capital will help us accelerate even faster into the next level, as well as being a huge vote of confidence in our vision to continue supporting the local economy with hundreds of jobs in the near future."
The London-based growth capital firm has launched a £1m fund headed by Parminder Basran to back early-stage technology companies.
"As a growth capital investment firm, we want to support new companies built around the voice economy, and this is an excellent opportunity to help British voice start-ups take their business to a level where they can raise follow-on capital from VGC Partners, other venture capital investors or corporate companies."
